Company Filing History:
Years Active: 2018
Title: Thorleif Moller: Innovator in RNA Modulation and Vascular Research
Introduction
Thorleif Moller is a notable inventor based in Vejle, Denmark. He has made significant contributions to the field of molecular biology, particularly in the modulation of RNA activity and vascular permeability. His innovative work has implications for treating various vascular-related diseases and conditions.
Latest Patents
Thorleif Moller holds a patent for the invention titled "Modulation of RNA activity and vascular permeability." This patent provides oligonucleotides that inhibit the binding of miR-27a to VE-cadherin mRNA, particularly in the form of blockmirs. The invention also includes compositions comprising such oligonucleotides and methods for their use to modulate the activity of VE-cadherin. This work aims to inhibit or reduce vascular permeability, treat or prevent vascular permeability-associated diseases, inhibit tumor growth, treat ischaemic injury, enhance recovery from ischaemic injury, treat surgical wounds, promote post-operative recovery, and induce angiogenesis.
Career Highlights
Thorleif Moller is affiliated with the University of Newcastle Upon Tyne, where he continues to advance his research in the field. His work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Thorleif has collaborated with notable colleagues, including Jennifer Gamble and Mathew Vadas, to further his research initiatives and enhance the impact of his inventions.
Conclusion
Thorleif Moller is a distinguished inventor whose work in RNA modulation and vascular research holds promise for significant advancements in medical science. His contributions are paving the way for innovative treatments and therapies that could benefit many individuals.